Key takeaways
These excerpts come from the original article. Read the full sections below for context.
- Chronic hemolysis increases the likelihood of pigment gallstones. Right upper abdominal pain, fever, or worsening jaundice may require evaluation for gallbladder inflammation or bile duct obstruction, as well as other causes of abdominal pain. Not every abdominal episode is a sickle cell crisis. Conversely, finding a stone on ultrasound does not prove that it explains every episode. Symptoms, examination, laboratory results, and imaging need to be interpreted together.[S23][S36]
- ASH conditionally favors preoperative transfusion for operations requiring general anesthesia and lasting longer than one hour, with very low certainty of evidence. It emphasizes individual assessment of genotype, surgical risk, baseline hemoglobin, previous transfusion complications, and disease severity. The one-hour criterion does not mean that every shorter procedure is risk-free, and it is not a stand-alone instruction for a patient to request blood.[S35]
- Useful discharge records include the operation and anesthetic course, transfusion details, medication changes, wound and activity instructions, and what to do about fever, chest symptoms, or new neurological changes. Medicines should be identifiable by generic name. Antibody records and recent hemoglobin results need to be accessible to the next clinician. Patients from another city or country should establish who will review recovery and whether they need to remain near the treating center initially.
Quick answer
People with sickle cell disease often worry that an operation or anesthetic will trigger a crisis. That concern deserves a detailed answer, but it does not mean that every operation should be avoided. The reason for surgery depends on the local problem being treated. Reducing perioperative risk requires a coordinated plan involving surgery, anesthesia, hematology, and the blood bank. Patients need to understand both before making a decision.[S48][S35]
Full guide
People with sickle cell disease often worry that an operation or anesthetic will trigger a crisis. That concern deserves a detailed answer, but it does not mean that every operation should be avoided. The reason for surgery depends on the local problem being treated. Reducing perioperative risk requires a coordinated plan involving surgery, anesthesia, hematology, and the blood bank. Patients need to understand both before making a decision.[S48][S35]
Gallbladder removal, splenectomy, and hip replacement usually address complications associated with the disease. They do not change the inherited diagnosis, and continuing sickle cell care may still be necessary afterward. At the same time, postponing a clearly indicated procedure can allow pain, infection, or disability to worsen. The consultation should explain what this operation can achieve and how the patient's particular blood disorder will be managed around it.
Gallstones require an assessment of what is causing the symptoms
Chronic hemolysis increases the likelihood of pigment gallstones. Right upper abdominal pain, fever, or worsening jaundice may require evaluation for gallbladder inflammation or bile duct obstruction, as well as other causes of abdominal pain. Not every abdominal episode is a sickle cell crisis. Conversely, finding a stone on ultrasound does not prove that it explains every episode. Symptoms, examination, laboratory results, and imaging need to be interpreted together.[S23][S36]
Symptomatic gallstone disease may lead to a recommendation for cholecystectomy. Asymptomatic stones require a separate discussion about observation and the timing of any intervention. Ask whether a common bile duct stone or infection is present, whether an additional endoscopic procedure is needed, and whether treatment is elective or urgent. Comparing incision size alone misses the effects of active inflammation, anesthesia, and postoperative respiratory risk on recovery.
Laparoscopic surgery still needs a complete perioperative plan. “Minimally invasive” describes the surgical approach; it does not remove sickle cell considerations. Previous acute chest syndrome, usual analgesic requirements, and difficulty finding compatible blood should be discussed before admission when possible. New fever or respiratory symptoms before the planned date should be reported rather than concealed to avoid postponement.
Acute splenic sequestration and elective splenectomy are different decisions
Acute splenic sequestration can trap a substantial volume of red cells in the spleen, causing rapidly worsening anemia and circulatory compromise. A child with left-sided abdominal pain, marked pallor, sudden weakness, rapid breathing or heartbeat, or a spleen that is noticeably larger than usual needs urgent medical attention. Parents who have been taught how to monitor spleen size can report the change, but should not delay seeking help while repeatedly examining the child.[S50]
Splenectomy may be discussed after recurrent or severe sequestration, persistent hypersplenism, or another specific indication. Enlargement alone does not automatically mean that the spleen should be removed. Age, genotype, splenic function, the history of episodes, and alternative strategies matter. Stabilization and transfusion during an acute emergency are related to, but distinct from, the later decision about elective surgery.[S36]
Because the spleen contributes to protection against infection, vaccination, preventive antibiotics where indicated, and a fever action plan should be reviewed before removal. Those protections remain important afterward. Preventive treatment in children depends on age and risk, and splenectomy changes that assessment. Removing a spleen that traps blood does not make future fever harmless, and patients should not stop an existing preventive prescription on their own.[S3][S41]
Persistent hip pain needs assessment for structural damage
Pain consistently affecting one hip, progressive walking difficulty, or loss of joint movement may warrant investigation for osteonecrosis of the femoral head. Structural pain can coexist with vaso-occlusive pain. Having sickle cell disease is not a reason to omit an orthopedic assessment. Imaging should help explain the extent of damage, whether collapse has occurred, and the implications for function rather than leaving the patient with a vague description of “bad bone.”[S23][S51]
Earlier disease may lead to discussion of joint protection, rehabilitation, or selected joint-preserving procedures. Advanced collapse with substantial functional loss may lead to a discussion of replacement. Results of a joint-preserving procedure in osteonecrosis generally are not automatically equivalent to results in every person with sickle cell disease. Ask whether the evidence fits your stage and whether the intended goal is pain relief, delayed collapse, or improved mobility.
Rehabilitation needs practical detail: when weight bearing is allowed, whether a walking aid is required, whether there are stairs at home, and how much standing a job involves. Anemia, sickle-related pain, and infection concerns may affect the pace. A video showing another patient walking soon after surgery cannot establish your recovery schedule. A return flight should not determine when you put additional weight through a recovering joint.
Preoperative assessment includes what happened in the past
Alongside the tests needed for the operation, the team needs the genotype, baseline hemoglobin, recent admissions, previous stroke, kidney or lung disease, sleep-related breathing problems, infections, and complications of earlier anesthesia. Additional heart and lung tests should respond to symptoms, known abnormalities, and procedural risk. Every patient does not need the same maximal panel of investigations.[S48][S7]
The medication list should include hydroxyurea, chelation, analgesics, anticoagulants, and supplements. The responsible teams should specify which medicines continue and which are temporarily adjusted. Someone who regularly uses opioid analgesia may need a different postoperative pain regimen; that is individualized care rather than evidence of inappropriate behavior. Underreporting usual doses can lead to inadequate relief or confused transitions after surgery.[S4]
Transfusion records are particularly valuable. Bring previous red cell antibody findings, serious reactions, matching requirements, and dates of recent transfusions. A currently negative antibody screen does not erase a historical antibody. The blood bank may need additional time to locate suitable units. Sharing records early is much more useful than discovering a difficult compatibility problem on the evening before surgery.[S35]
Preoperative transfusion is not a uniform instruction for every patient
ASH conditionally favors preoperative transfusion for operations requiring general anesthesia and lasting longer than one hour, with very low certainty of evidence. It emphasizes individual assessment of genotype, surgical risk, baseline hemoglobin, previous transfusion complications, and disease severity. The one-hour criterion does not mean that every shorter procedure is risk-free, and it is not a stand-alone instruction for a patient to request blood.[S35]
The randomized TAPS study supports reduced perioperative complications with transfusion in the particular sickle cell population and elective surgical settings studied. Its participants and procedures still define the limits of the finding. Choosing simple transfusion or red cell exchange also requires consideration of the starting hemoglobin and viscosity. Raising hemoglobin as high as possible is not an appropriate safety target.[S49][S35]
A history of severe delayed hemolytic transfusion reactions requires a particularly careful balance. It should not be ignored because transfusion is commonly used before an operation. Conversely, lifesaving emergency surgery should not be delayed simply to complete an elective preparation pathway. Surgery, anesthesia, and hematology should agree on the decision and explain the available intraoperative and postoperative blood support.
Anesthesia and recovery need respiratory and circulatory protection
The perioperative team pays attention to hypoxia, low temperature, acid-base disturbances, dehydration, and fluid overload. More intravenous fluid is not necessarily better; excess fluid can add to pulmonary problems. Patients should describe their usual oxygen saturation if known, any home oxygen or respiratory device, and previous acute chest syndrome so that postoperative changes can be interpreted in context.[S48]
Pain relief must be assessed together with alertness, breathing, and movement. Pain that prevents deep breaths or mobilization can interfere with recovery, while excessive sedation also requires avoidance. Staff may teach breathing exercises or incentive spirometry and arrange activity when appropriate. Patients do not need to invent their own frequency of exercises, but should know who will teach the technique and whom to tell when pain prevents participation.[S36][S4]
New chest pain, fever, breathlessness, or reduced oxygenation should be reported promptly rather than assumed to be an ordinary anesthetic after-effect. Acute chest syndrome can develop after surgery. A swollen painful leg or abrupt breathlessness also requires consideration of thrombosis and other causes. Drug or mechanical clot prevention should reflect the procedure, bleeding risk, and individual history rather than unsupervised self-medication.[S23][S48]
Some urgent procedures cannot wait for long-term treatment to work
A persistent painful erection, particularly one reaching four hours, requires emergency urologic assessment. Acute ischemic priapism needs prompt relief of local ischemia. Waiting for hydroxyurea to work, or delaying indicated urologic treatment while arranging exchange transfusion, can cause harm. The AUA and SMSNA guideline advises against exchange transfusion as the primary treatment in this setting. Cold packs can also aggravate sickle-related problems and should not be used as a home substitute for urgent assessment.[S52]
Eye procedures and neurosurgical interventions likewise depend on the actual lesion. Retinal complications need ophthalmic assessment; laser treatment is not a systemic treatment for sickle cell disease. In selected patients with moyamoya-type cerebrovascular changes and previous stroke or transient ischemic attacks, cerebral revascularization may be considered by specialists. That discussion does not authorize independently replacing an established transfusion-based stroke-prevention plan.[S40][S6]
Plan discharge before the operation
Useful discharge records include the operation and anesthetic course, transfusion details, medication changes, wound and activity instructions, and what to do about fever, chest symptoms, or new neurological changes. Medicines should be identifiable by generic name. Antibody records and recent hemoglobin results need to be accessible to the next clinician. Patients from another city or country should establish who will review recovery and whether they need to remain near the treating center initially.
When arranging surgery in China, confirm both the relevant surgical expertise and the sickle cell support arrangements: hematology consultation, complex compatibility testing, postoperative monitoring, and emergency care. The existence of a surgical service does not prove that an appropriate blood support plan has been secured for this patient. Length of stay and overall cost need individual clarification after assessment of the condition, procedure, and transfusion requirements; another patient's bill is not a promise.
A workable plan enables the patient to explain why surgery is proposed now, what may happen if it is deferred, how blood and anesthesia risks will be managed, and who takes responsibility for problems during recovery. If the date or pace of rehabilitation changes, those arrangements provide a medical explanation and a route forward rather than leaving the family to manage the change alone.
Sources
- [S3] NHLBI: Sickle cell disease treatment
- [S4] ASH 2020: Acute and chronic pain in sickle cell disease
- [S6] ASH 2020: Cerebrovascular disease in children and adults
- [S7] ASH 2019: Cardiopulmonary and kidney disease
- [S23] NHLBI: How sickle cell disease may affect your health
- [S35] ASH 2020 transfusion guideline full text: antigen matching, delayed reactions and iron MRI
- [S36] NHLBI 2014 full expert report: monitoring hydroxyurea
- [S40] CDC: Vision loss in sickle cell disease
- [S41] WHO 2026 childhood sickle cell guideline: Full recommendations
- [S48] ASH Education Program: Optimizing perioperative sickle cell management
- [S49] NHS Blood and Transplant: TAPS randomized perioperative transfusion trial
- [S50] CDC: Splenic sequestration in sickle cell disease
- [S51] AAOS OrthoInfo: Osteonecrosis of the hip
- [S52] AUA and SMSNA 2022: Diagnosis and management of priapism
Related guides
- Sickle Cell Disease Treatment: Preventing Crises, Protecting Organs, and Considering Transformative Therapy
- 20 Questions About Sickle Cell Disease: Medicines, Transfusion, Gene Therapy, and Care in China
- Comparing Sickle Cell Treatments: Medicines, Transfusion, Transplantation, and Gene Therapy
- Checking Sickle Cell Medicines: Hydroxyurea, Regulatory Updates, Pain Relief, and Monitoring